ARDS Meeting Notes
The ARDS provides participants with a Meeting Notes PDF which includes most slide presentations from the meeting. The Meeting Notes are taken and assembled by talented and rising retinal stars. They attend every talk and capture the essence of the vigorous post-talk discussion, for which the ARDS is deservedly famous.
Please email ards@medconfs.com to request a copy of the Meeting Notes. Be sure to include the year(s) requested.
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
| Past ARDS Speakers “The list is huge. Many of us are very cognizant of the fact that we truly do stand on the shoulders of giants. In retina, many of the giants came regularly to that meeting. I remember very vividly being there with everyone from Tom Aaberg, Sr. to Steve Charles to Don Gass, many of the real luminaries in our field… Here was an opportunity to not only listen, but to stand up in front of your peers and probe into important clinical questions in a forum that not only permitted it, but encouraged it.” David Parke, II |
|
|---|---|
| Records per page: | |
| 2022 50th Annual Meeting | |
| H. Culver Boldt, MD | Vitreoretinal Surgery for Inherited Retinal Disease |
| Steve T. Charles, MD | Autologous Retinal Transplant |
| Steve T. Charles, MD | Medium Term PFO for Inferior Retinal Detachments and Inferior, Nasal, and Temporal Giant Breaks |
| K. Bailey Freund, MD | How Understanding the Histologic Basis of Retinal Imaging Findings in AMD Can Improve Current and Future Patient Outcomes |
| K. Bailey Freund, MD | New Imaging Findings from High-Res OCT |
| Judy E. Kim, MD, FARVO, FASRS | Artificial Intelligence and Retinal Imaging |
| Judy E. Kim, MD, FARVO, FASRS | Diabetic Retinopathy Management |
| Joan W. Miller, MD | Future Treatments for Early and Intermediate AMD |
| Joan W. Miller, MD | Neuroprotection for Retinal Disease |
| Timothy G. Murray, MD, MBA | Advances in Ocular Oncology - Three Decades Define Patient Care |
| Aleksandra V. Rachitskaya, MD | Gene Therapies for Inherited Retinal Diseases: Imaging Advances that Impact Care |
| Aleksandra V. Rachitskaya, MD | Short- and Long-Term Outcomes of Delays in Care in Patients Receiving Intraocular Injections |
| Carl D. Regillo, MD | Faricimab for Neovascular AMD and DME |
| Carl D. Regillo, MD | Update on the Port Delivery System |
| Panel Discussion | Advanced Retinal Care: What Does the Future Hold? |
| Panel Discussion | Advances and Controversies in AMD |
| Panel Discussion | Surgical Advances in Complex Retina |
| 2021 49th Annual Meeting | |
| Robert L. Avery, MD | Anti-VEGF for Retinal Disease: An Interesting Journey, And Where We Are Headed |
| Maria H. Berrocal, MD | Early Vitrectomy Surgical Intervention Recovers Both Visual Acuity and Function |
| Maria H. Berrocal, MD | Transitioning to Small Gauge Vitrectomy Surgery |
| R.V. Paul Chan, MD, MSc, MBA, FACS | The International Classification of ROP: 1984 to 2021 |
| R.V. Paul Chan, MD, MSc, MBA, FACS | Treatment of Pediatric Retina Patients in the Era of Laser and Anti-VEGF |
| Dennis P. Han, MD | Anti-VEGF Therapy of Neovascular AMD with Advanced Visual Loss: Going Where Few Randomized Trials Have Gone Before |
| Dennis P. Han, MD | Preventing Endophthalmitis After Intravitreal Injections: What Do We Know? |
| Allen C. Ho, MD, FACS | Surgical Considerations for Gene and Cell Therapy 2021 |
| PREV | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 | NEXT |
